294 related articles for article (PubMed ID: 25540827)
1. Optimization of tetracycline hydrochloride adsorption on amino modified SBA-15 using response surface methodology.
Hashemikia S; Hemmatinejad N; Ahmadi E; Montazer M
J Colloid Interface Sci; 2015 Apr; 443():105-14. PubMed ID: 25540827
[TBL] [Abstract][Full Text] [Related]
2. Preparation of efficient quercetin delivery system on Zn-modified mesoporous SBA-15 silica carrier.
Trendafilova I; Szegedi A; Mihály J; Momekov G; Lihareva N; Popova M
Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():285-292. PubMed ID: 28183610
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and surface modification of mesoporous silica nanoparticles and its application as carriers for sustained drug delivery.
Ahmadi E; Dehghannejad N; Hashemikia S; Ghasemnejad M; Tabebordbar H
Drug Deliv; 2014 May; 21(3):164-72. PubMed ID: 24116869
[TBL] [Abstract][Full Text] [Related]
4. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system.
Yang P; Huang S; Kong D; Lin J; Fu H
Inorg Chem; 2007 Apr; 46(8):3203-11. PubMed ID: 17371013
[TBL] [Abstract][Full Text] [Related]
5. Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix-drug interactions.
Song SW; Hidajat K; Kawi S
Langmuir; 2005 Oct; 21(21):9568-75. PubMed ID: 16207037
[TBL] [Abstract][Full Text] [Related]
6. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization.
Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA
Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529
[TBL] [Abstract][Full Text] [Related]
7. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
8. In vitro controlled release of antihypertensive drugs intercalated into unmodified SBA-15 and MgO modified SBA-15 matrices.
Alexa IF; Ignat M; Popovici RF; Timpu D; Popovici E
Int J Pharm; 2012 Oct; 436(1-2):111-9. PubMed ID: 22743006
[TBL] [Abstract][Full Text] [Related]
9. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
[TBL] [Abstract][Full Text] [Related]
10. Functionalized ionic liquid modified mesoporous silica SBA-15: a novel, designable and efficient carrier for porcine pancreas lipase.
Zou B; Hu Y; Yu D; Jiang L; Liu W; Song P
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):93-9. PubMed ID: 21872768
[TBL] [Abstract][Full Text] [Related]
11. [Structure and adsorption characterization of SBA-16 and functionalized materials].
Zheng Z; Guo G; Hu Y; Feng F; Xu G; Tan H
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Aug; 28(4):768-73. PubMed ID: 21936378
[TBL] [Abstract][Full Text] [Related]
12. Functionalized silica nanoparticles as a carrier for Betamethasone Sodium Phosphate: Drug release study and statistical optimization of drug loading by response surface method.
Ghasemnejad M; Ahmadi E; Mohamadnia Z; Doustgani A; Hashemikia S
Mater Sci Eng C Mater Biol Appl; 2015 Nov; 56():223-32. PubMed ID: 26249584
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, amino-functionalization of mesoporous silica and its adsorption of Cr(VI).
Li J; Miao X; Hao Y; Zhao J; Sun X; Wang L
J Colloid Interface Sci; 2008 Feb; 318(2):309-14. PubMed ID: 18036539
[TBL] [Abstract][Full Text] [Related]
14. Citric acid functionalized silane coupling versus post-grafting strategy for dual pH and saline responsive delivery of cisplatin by Fe
Abedi M; Abolmaali SS; Abedanzadeh M; Borandeh S; Samani SM; Tamaddon AM
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109922. PubMed ID: 31499936
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization and application of p-tert-butyl-calix[4]arene-SBA-15 mesoporous silica molecular sieves.
Huang H; Zhao C; Ji Y; Nie R; Zhou P; Zhang H
J Hazard Mater; 2010 Jun; 178(1-3):680-5. PubMed ID: 20185235
[TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
[TBL] [Abstract][Full Text] [Related]
17. Ordered mesoporous silica modified with lanthanum for ibuprofen loading and release behaviour.
Goscianska J; Olejnik A; Nowak I; Marciniak M; Pietrzak R
Eur J Pharm Biopharm; 2015 Aug; 94():550-8. PubMed ID: 26170160
[TBL] [Abstract][Full Text] [Related]
18. Nanostructured SBA-15 host applied in ketorolac tromethamine release system.
Cussa J; Juárez JM; Gómez Costa MB; Anunziata OA
J Mater Sci Mater Med; 2017 Aug; 28(8):113. PubMed ID: 28625001
[TBL] [Abstract][Full Text] [Related]
19. Inclusion of fenofibrate in a series of mesoporous silicas using microwave irradiation.
Waters LJ; Hussain T; Parkes G; Hanrahan JP; Tobin JM
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):936-41. PubMed ID: 23954510
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of carboxyl-modified rod-like SBA-15 by rapid co-condensation.
Shen S; Chow PS; Kim S; Zhu K; Tan RB
J Colloid Interface Sci; 2008 May; 321(2):365-72. PubMed ID: 18328495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]